BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16757166)

  • 21. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
    Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
    J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase.
    Middendorp O; Lüthi U; Hausch F; Barberis A
    Biol Chem; 2004 Jun; 385(6):481-5. PubMed ID: 15255179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragment-based discovery of BACE1 inhibitors using functional assays.
    Godemann R; Madden J; Krämer J; Smith M; Fritz U; Hesterkamp T; Barker J; Höppner S; Hallett D; Cesura A; Ebneth A; Kemp J
    Biochemistry; 2009 Nov; 48(45):10743-51. PubMed ID: 19799414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
    Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
    J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228.
    Polgár T; Keserü GM
    J Med Chem; 2005 Jun; 48(11):3749-55. PubMed ID: 15916426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design.
    Park H; Lee S
    J Am Chem Soc; 2003 Dec; 125(52):16416-22. PubMed ID: 14692784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors.
    Rönn R; Gossas T; Sabnis YA; Daoud H; Kerblom E; Danielson UH; Sandström A
    Bioorg Med Chem; 2007 Jun; 15(12):4057-68. PubMed ID: 17449253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by KMI-574 leads to dislocalization of BACE1 from lipid rafts.
    Ebina M; Futai E; Tanabe C; Sasagawa N; Kiso Y; Ishiura S
    J Neurosci Res; 2009 Feb; 87(2):360-8. PubMed ID: 18798280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling the binding affinities of beta-secretase inhibitors: application to subsite specificity.
    Rajamani R; Reynolds CH
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4843-6. PubMed ID: 15341936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (beta-secretase).
    Ghosh AK; Devasamudram T; Hong L; DeZutter C; Xu X; Weerasena V; Koelsch G; Bilcer G; Tang J
    Bioorg Med Chem Lett; 2005 Jan; 15(1):15-20. PubMed ID: 15582402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-based discovery and optimization of BACE1 inhibitors.
    Madden J; Dod JR; Godemann R; Kraemer J; Smith M; Biniszkiewicz M; Hallett DJ; Barker J; Dyekjaer JD; Hesterkamp T
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5329-33. PubMed ID: 20656487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors.
    Asso V; Ghilardi E; Bertini S; Digiacomo M; Granchi C; Minutolo F; Rapposelli S; Bortolato A; Moro S; Macchia M
    ChemMedChem; 2008 Oct; 3(10):1530-4. PubMed ID: 18781572
    [No Abstract]   [Full Text] [Related]  

  • 37. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
    Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1.
    Kortum SW; Benson TE; Bienkowski MJ; Emmons TL; Prince DB; Paddock DJ; Tomasselli AG; Moon JB; LaBorde A; TenBrink RE
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3378-83. PubMed ID: 17434734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.
    Coburn CA; Stachel SJ; Li YM; Rush DM; Steele TG; Chen-Dodson E; Holloway MK; Xu M; Huang Q; Lai MT; DiMuzio J; Crouthamel MC; Shi XP; Sardana V; Chen Z; Munshi S; Kuo L; Makara GM; Annis DA; Tadikonda PK; Nash HM; Vacca JP; Wang T
    J Med Chem; 2004 Dec; 47(25):6117-9. PubMed ID: 15566281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
    Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
    Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.